Regulations.gov document
NDI 426 - Hyaluronic Acid or Sodium Hyaloronate from Aquaflex, Inc.
Other · FDA-2008-S-0664 · posted Mar 13, 2017
Key facts
| Document ID | FDA-2008-S-0664-0009 |
|---|---|
| Title | NDI 426 - Hyaluronic Acid or Sodium Hyaloronate from Aquaflex, Inc. |
| Document type | Other |
| Subtype | 75 Day PreMarket Notification |
| Agency | FDA |
| Docket | FDA-2008-S-0664 |
| Posted | Mar 13, 2017 |
| Comment period opens | Mar 13, 2017 |
At a glance
- None Pages
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: